Sami Labs appoints Neeraja Shetty as CEO

Published On 2020-03-12 03:30 GMT   |   Update On 2020-03-12 03:31 GMT

Bangalore: Sami-Sabinsa Group, has announced the appointment of Ms Neeraja Shetty as the Chief Executive Officer of Sami Labs (a part of Sami-Sabinsa Group). As the CEO, Neeraja will oversee and drive key functions of strategy, operations, supply chain, finance and new projects to help achieve the ambitious growth plans of the company. During her previous assignments with Sami Labs, Neeraja held the positions of CEO - Formulations between 2002 to 2008 and was the Director & President - Strategy & Business Development from 2011 to 2017. 

Speaking about her new role, Neeraja said, "It is an exciting time to join Sami Labs as the Group has chalked out an aggressive growth and expansion plan. I look forward to working with teams across the board to drive forward the vision of the organization which is to further consolidate its leadership position in the nutraceuticals and cosmeceuticals space".

Neeraja possesses over two and half decades of rich experience in the life sciences space and has held various senior management and leadership roles of increasing responsibility, both in India and abroad with a focus on strategy, business development and sales.

She started her career with Biocon and later relocated to Singapore to join Corporate Physicians International as a Country Manager for Singapore, India and Malaysia.

Neeraja also began a life science start-up entrepreneurial venture - Igenerix Pharma Pvt Ltd and ran it successfully.

Sami-Sabinsa Group,  is a  producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, speciality chemicals, and probiotics. Founded in 1988 by Dr Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Alternative Medicine, the Group has independent research divisions including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D, all of which coordinate in a synergistic work model to create products

Read also: Government grants research fund to Sami Labs under PACE scheme

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News